Research Tracker›Biomarker Atlas›Hepatitis C›Alpha-Fetoprotein

Alpha-Fetoprotein in Hepatitis C

In Hepatitis C, published studies report higher levels of Alpha-Fetoprotein than in healthy donors or disease controls. The source does not tie this marker to a specific symptom cluster, so it is best read as a biological signal rather than a symptom predictor. The evidence summarised here comes from Nakao et al. 2013 and reflects averages across cohorts rather than any single patient's result.

↑ ElevatedOther

Summary

Direction in Hepatitis C↑ Elevated — higher than in the comparison group
CategoryOther
Compared againsthealthy donors or disease controls
SourceNakao et al. 2013 — doi:10.1111/hepr.12052
Condition atlasHepatitis C Biomarker Atlas

Related Other markers in Hepatitis C

Full list: Hepatitis C Biomarker Atlas.

Frequently asked questions

Is Alpha-Fetoprotein high or low in Hepatitis C?

Elevated. Studies summarised in the OSMF atlas report higher Alpha-Fetoprotein in Hepatitis C than in healthy donors or disease controls. Source: Nakao et al. 2013.

Which test measures Alpha-Fetoprotein?

The atlas record does not list a standardised clinical test code (LOINC) for Alpha-Fetoprotein, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

Is one abnormal Alpha-Fetoprotein result diagnostic of Hepatitis C?

No. No single biomarker is diagnostic of Hepatitis C. Alpha-Fetoprotein findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). Alpha-Fetoprotein in Hepatitis C: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 8, 2026, from https://research.opensourcemed.info/biomarkers/hepatitis-c/alpha-fetoprotein.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-10-08 · Page generated from hepatitis-c.json · Browse: Hepatitis C atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.